CEBPA biallelic mutation analysis; CEBPA InDel analysis; CEBPA fragement analysis;

  • Tech Only CPT
  • Tech Pro CPT
  • PowerPath Code CEBPA
  • Schedule Monday - Friday
  • Turn Around Time 2-4 days
  • Disease State Acute Myeloid Leukemia (AML) / Myeloid Sarcoma
  • Methodology PCR based fragment analysis by capillary electrophoresis


Bone marrow or pheripheral blood

Specimen Requirements

Container Type: Lavender top tube (EDTA)
Specimen Type: Whole Blood; Bone Marrow
Preferred Volume: 5mL Whole Blood; 2 mL Bone Marrow
Minimum Volume: 3 mL Whole Blood; 1 mL Bone Marrow
Bone marrow clot if no fresh specimen available

Diagnostic Utility

CEBPA biallelic mutations have been used as indicator for risk stratification on prognosis for cytogenetically normal acute myeloid leukemia (CN-AML).

Storage and Transportation

Refrigerated: 5 days
Ambient (room temperature): 3 days

Cause for Rejection

Serum or plasma. Frozen specimens. Clotted whole blood. Severely hemolyzed specimens. 


one week - whole blood. DNA - 2 years.


Copy of the referring client's requisition form to accompany specimen.
Results of this test must always be interpreted in the context of relevant clinical and pathological data, and should not be used alone for a diagnosis of malignancy.